Merck and Inbrain Neuroelectronics collaborate on graphene-based bioelectronic therapy technology [13-07-2021]
Major pharma company Merck has announced a collaboration agreement with Innervia Bioelectronics, a start-up and subsidiary of Inbrain Neuroelectronics S.L., Barcelona, Spain. The aim of the collaboration is to co-develop the next generation of graphene-based bioelectronic vagus nerve therapies targeting severe chronic diseases within the therapeutic areas addressed by Merck.
Related News
Elon Musk`s Neuralink is being outperformed by the Spanish graphene startup Inbrain [08-07-2021]
A template for fast synthesis of nanographenes [06-07-2021]
Researchers observe sound-light pulses in 2D materials for the first time [14-06-2021]
Nanophotonics & Nano-Optoelectronics, Graphene, 2D Materials
Novel nano-encapsulation approach for efficient dopamine delivery in Parkinson`s treatment [02-06-2021]
Nanobiotechnology, Nanomedicine
The GRAPES Spearhead Project: Graphene Perovskite Panels and the Future of Solar Energy [28-05-2021]
Energy, Graphene

© Phantoms Foundation 2021